Basket cover image
4 handpicked stocks

Dating Apps

Do dating apps present investment opportunities that will get your heart beating faster? This collection of carefully selected stocks represents companies transforming how people connect and find relationships in the digital age.

stock
stock
stock
stock
Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at मई 9

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

MTCH

Match Group, Inc.

MTCH

Current price

$37.85

BMBL

Bumble Inc.

BMBL

Current price

$6.38

GRND

Grindr Inc

GRND

Current price

$15.97

About This Group of Stocks

1

Our Expert Thinking

The online dating industry has evolved from novelty to mainstream necessity, creating a $3 billion market projected to grow 5.3% annually through 2026. These platforms gained significant traction during the pandemic as people sought digital connections during social distancing.

2

What You Need to Know

These companies provide diverse approaches to digital relationship-building, from female-first platforms to LGBTQ+-focused apps. The pandemic accelerated adoption of online dating, creating increased user engagement and expanding revenue opportunities.

3

Why These Stocks

This collection represents leaders across the digital dating landscape, each with unique market positioning and growth potential. Selected by professional analysts, these companies demonstrate strong market presence in an industry seeing increasing social acceptance and usage.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+34.26%

Group Performance Snapshot

34.26%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 34.26% over the next year.

2 of 4

Stocks Rated Buy by Analysts

2 of 4 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

📱

Digital Romance Revolution

Dating has permanently moved online, with millions of new users joining these platforms yearly. This growing acceptance creates expanding revenue streams for the companies leading the market.

📈

Pandemic-Proven Growth

These companies demonstrated resilience during global lockdowns, gaining users when traditional dating wasn't possible. This proven adaptability shows their potential in both challenging and normal market conditions.

💲

$4.23 Billion Market Potential

The dating app industry is projected to reach $4.23 billion by 2026. Getting in early on these established players could position you to benefit from this massive market expansion.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.